1. Home
  2. TROX vs PRAX Comparison

TROX vs PRAX Comparison

Compare TROX & PRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tronox Holdings plc (UK)

TROX

Tronox Holdings plc (UK)

HOLD

Current Price

$6.98

Market Cap

1.0B

Sector

Industrials

ML Signal

HOLD

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

HOLD

Current Price

$293.73

Market Cap

9.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TROX
PRAX
Founded
2018
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
9.6B
IPO Year
2012
2020

Fundamental Metrics

Financial Performance
Metric
TROX
PRAX
Price
$6.98
$293.73
Analyst Decision
Hold
Strong Buy
Analyst Count
8
15
Target Price
$6.07
$572.13
AVG Volume (30 Days)
4.1M
321.1K
Earning Date
05-20-2026
01-01-0001
Dividend Yield
2.95%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,898,000,000.00
N/A
Revenue This Year
$6.49
N/A
Revenue Next Year
$4.86
$6,395.88
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.86
$26.70
52 Week High
$8.80
$354.87

Technical Indicators

Market Signals
Indicator
TROX
PRAX
Relative Strength Index (RSI) 50.92 37.08
Support Level $5.02 $290.36
Resistance Level $7.84 $322.32
Average True Range (ATR) 0.50 17.42
MACD -0.10 -5.25
Stochastic Oscillator 44.01 7.97

Price Performance

Historical Comparison
TROX
PRAX

About TROX Tronox Holdings plc (UK)

Tronox Holdings PLC is a vertically integrated manufacturer of TiO2 pigment. It operates titanium-bearing mineral sand mines and beneficiation and smelting operations in Australia & South Africa to produce feedstock materials that can be processed into TiO2 for pigment, high-purity titanium chemicals, including titanium tetrachloride, and ultrafine TiO2 used in certain specialty applications. TiO2 and titanium feedstock, are used to produce paints and coatings, as well as plastics, paper, and printing ink. It has three pigment production facilities in the United States, the Netherlands, and Western Australia and three mining operations in Western Australia and South Africa. Europe, the Middle East, and Africa regions contribute the majority of revenue.

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

Share on Social Networks: